UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

BAP1, Wilms’ tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma

Journal of cancer research and clinical oncology, 2024-01, Vol.150 (2), p.38-38, Article 38

2024

Link zum Volltext

Verfügbarkeit prüfen

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Annals of surgical oncology, 2016-05, Vol.23 (5), p.1468-1473

2016

Link zum Volltext

Verfügbarkeit prüfen

Use of Immune Checkpoint Inhibitors in Mesothelioma

Current treatment options in oncology, 2019-02, Vol.20 (2), p.18-18, Article 18

2019

Link zum Volltext

Verfügbarkeit prüfen

The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer

Cancer chemotherapy and pharmacology, 2018-01, Vol.81 (1), p.1-15

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma

Molecular biology reports, 2019-06, Vol.46 (3), p.2713-2720

2019

Link zum Volltext

Verfügbarkeit prüfen

Genes and Pathways Involved in the Progression of Malignant Pleural Mesothelioma: A Meta-analysis of Genome-Wide Expression Studies

Biochemical genetics, 2024-02, Vol.62 (1), p.352-370

2024

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray

Annals of surgical oncology, 2015-12, Vol.22 (13), p.4344-4351

2015

Link zum Volltext

Verfügbarkeit prüfen

Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment

Annals of surgical oncology, 2016-05, Vol.23 (5), p.1496-1500

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma

Investigational new drugs, 2021-06, Vol.39 (3), p.644-657

2021

Link zum Volltext

Verfügbarkeit prüfen

Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial–mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis

Archives of Pharmacal Research, 2019, 42(10), , pp.890-901

2019

Link zum Volltext

Verfügbarkeit prüfen

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

Investigational new drugs, 2018-04, Vol.36 (2), p.217-229

2018

Link zum Volltext

Verfügbarkeit prüfen

Pleural mesothelioma classification update

Virchows Archiv : an international journal of pathology, 2021, Vol.478 (1), p.59-72

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumoral CD10 Expression Correlates with Aggressive Histology and Prognosis in Patients with Malignant Pleural Mesothelioma

Annals of surgical oncology, 2015-09, Vol.22 (9), p.3136-3143

2015

Link zum Volltext

Verfügbarkeit prüfen

Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study

Annals of surgical oncology, 2013-11, Vol.20 (12), p.3892-3898

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure

Analytical and bioanalytical chemistry, 2010-12, Vol.398 (7-8), p.3043-3050

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas

Virchows Archiv : an international journal of pathology, 2008-12, Vol.453 (6), p.627-635

2008

Link zum Volltext

Verfügbarkeit prüfen

Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma

Virchows Archiv : an international journal of pathology, 2013-01, Vol.462 (1), p.83-93

2013

Link zum Volltext

Verfügbarkeit prüfen

FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival

European journal of nuclear medicine and molecular imaging, 2011-05, Vol.38 (5), p.810-821

2011

Link zum Volltext

Verfügbarkeit prüfen

Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas

Virchows Archiv : an international journal of pathology, 2021, Vol.478 (1), p.73-80

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının

Pathology oncology research, 2017-07, Vol.23 (3), p.487-491

2017

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal Cytokine Level in Patients with Peritoneal Surface Malignancies. A Study of the RENAPE (French Network for Rare Peritoneal Malignancies)

Annals of surgical oncology, 2013-08, Vol.20 (8), p.2655-2662

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Piroxicam Plus Cisplatin-Loaded PLGA Nanoparticles in Inducing Apoptosis in Mesothelioma Cells

Pharmaceutical research, 2015-02, Vol.32 (2), p.362-374

2015

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA

Medical oncology (Northwood, London, England), 2013-06, Vol.30 (2), p.543-543, Article 543

2013

Link zum Volltext

Verfügbarkeit prüfen

Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients

Clinical & translational oncology, 2020-08, Vol.22 (8), p.1390-1398

2020

Link zum Volltext

Verfügbarkeit prüfen

Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis

Molecular and cellular biochemistry, 2011-11, Vol.357 (1-2), p.83-94

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 140

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Immunology, Immunotherapy : Cii

PublikationsformNewsletter-Artikel

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(140)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BAP1, Wilms’ tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Use of Immune Checkpoint Inhibitors in Mesothelioma

The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer

Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma

Genes and Pathways Involved in the Progression of Malignant Pleural Mesothelioma: A Meta-analysis of Genome-Wide Expression Studies

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray

Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma

Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial–mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

Pleural mesothelioma classification update

Tumoral CD10 Expression Correlates with Aggressive Histology and Prognosis in Patients with Malignant Pleural Mesothelioma

Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study

Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas

Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma

FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival

Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas

The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının

Intraperitoneal Cytokine Level in Patients with Peritoneal Surface Malignancies. A Study of the RENAPE (French Network for Rare Peritoneal Malignancies)

Efficacy of Piroxicam Plus Cisplatin-Loaded PLGA Nanoparticles in Inducing Apoptosis in Mesothelioma Cells

Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA

Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients

Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis

Aktive Filter

Suchergebnisse filtern